Delayed access to care and late presentations in children during the COVID-19 pandemic New Zealand-wide lockdown: A New Zealand Paediatric Surveillance Unit study.


Journal

Journal of paediatrics and child health
ISSN: 1440-1754
Titre abrégé: J Paediatr Child Health
Pays: Australia
ID NLM: 9005421

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 04 03 2021
accepted: 30 04 2021
pubmed: 19 5 2021
medline: 6 10 2021
entrez: 18 5 2021
Statut: ppublish

Résumé

Describe paediatricians' experience of adverse health outcomes for children during the New Zealand-wide level 4 lockdown in response to the COVID-19 pandemic. Weekly national survey of paediatricians with an open-ended questionnaire. During the 6-week study survey period, the New Zealand Paediatric Surveillance Unit received 33 reports about 55 instances where paediatricians believed care may have been compromised, about half (56%) relating to infants aged from birth to 6 weeks. Compromised care was for acute presentations in 75%, acute complications of a chronic illness in 14%, with 11% for chronic conditions. Paediatricians reported the outcome as moderately severe (short-term morbidity, increased length of stay, higher level of care) in 38 cases (69%) and in a further 4 (7%) as severe (potential to be life-threatening or result in permanent disability). Despite clear messaging, hospital avoidance and reduced access to primary and secondary care were associated with significant potential harm for children in New Zealand during a strict lockdown, with newborn infants disproportionately affected. During the implementation of interventions to eliminate community transmission of COVID-19, New Zealand paediatricians note the importance of face-to-face post-natal visits for newborns and primary care services for children with acute illness, to avoid preventable harm.

Identifiants

pubmed: 34003540
doi: 10.1111/jpc.15551
pmc: PMC8242550
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1600-1604

Subventions

Organisme : Ministry of Health

Informations de copyright

© 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Arch Dis Child. 2020 Jul;105(7):704
pubmed: 32376695
Int J Environ Res Public Health. 2020 Sep 15;17(18):
pubmed: 32942698
Lancet Public Health. 2020 Nov;5(11):e569-e570
pubmed: 33065024
Emerg Infect Dis. 2021 Feb;27(2):641-643
pubmed: 33263515
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Arch Dis Child. 2020 Aug;105(8):810-811
pubmed: 32518141
Arch Dis Child. 2020 Jul;105(7):704-706
pubmed: 32461213
Lancet Public Health. 2020 Nov;5(11):e612-e623
pubmed: 33065023
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
Arch Dis Child. 2007 Jun;92(6):527-33
pubmed: 17158859
Acta Paediatr. 2020 Aug;109(8):1672-1676
pubmed: 32460364
BMC Pediatr. 2020 Dec 23;20(1):562
pubmed: 33353540
Arch Dis Child. 2021 Feb;106(2):e8
pubmed: 32586927
Lancet. 2020 May 9;395(10235):1474
pubmed: 32386582
Int J Epidemiol. 2021 Jan 23;49(6):2089-2091
pubmed: 32929454

Auteurs

Mavis Duncanson (M)

Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Benjamin J Wheeler (BJ)

Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Timothy Jelleyman (T)

Child and Youth Team, Population Health and Prevention Directorate, New Zealand Ministry of Health, Wellington, New Zealand.

Stuart R Dalziel (SR)

Department of Surgery, The University of Auckland, Auckland, New Zealand.
Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.
Children's Emergency Department, Starship Children's Health, Auckland, New Zealand.

Peter McIntyre (P)

Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH